KRM Ayurveda Ltd. (KRMAYURVED-SM): KRM Ayurveda Share Price Rises 10.6% as Micro Cap Stock Clears Threshold

KRM Ayurveda Share Price Today stood at Rs 334, up 10.6%, lifting market capitalisation to Rs 642.08 crore in a qualifying Micro Cap price rise event.

KRM Ayurveda Share Price moved sharply higher on 10 August 2026, with the stock trading at Rs 334, up Rs 32 or 10.6% from the previous close of Rs 302. With market capitalisation at Rs 642. In Stock Market Today terms, that places KRM Ayurveda Ltd. among the notable market movers being tracked for confirmed price action rather than speculation.

The supplied data confirms the price event, strong intraday participation and a meaningful move above the prior close, but it does not establish a company-specific catalyst for why the stock is rising today. That distinction matters in KRM Ayurveda Stock News because a same-day share price gain can become a talking point even when the reason is not verified by the supplied inputs. Univest therefore focuses here on what is confirmed: price, turnover, volume, valuation, peer positioning and Healthcare industry context.

KRM Ayurveda Share Price Today also reflects a session in which the stock opened at Rs 312, touched a day high of Rs 343.95 and did not fall below its opening level, with the day low also at Rs 312. That keeps attention on both momentum and structure. For investors following KRM Ayurveda Share Price Live, the next points to monitor are whether volume support remains sustained, how valuation compares with peers, and whether the company’s profitability metrics continue to justify investor attention. This Univest analysis reviews the stock move through price action, fundamental analysis, peer comparison and industry data.

KRM Ayurveda Ltd. (KRMAYURVED-SM) Share Price Today: Price Action Analysis

KRM Ayurveda Ltd. (KRMAYURVED-SM) traded at Rs 334. versus the previous close of Rs 302, a rise of 10.6%. The stock opened at Rs 312, reached Rs 343.95, touched Rs 312. Reported volume was 1,57,000.

KRM Ayurveda Ltd. (KRMAYURVED-SM) Fundamental Analysis

KRM Ayurveda Ltd. was valued at a P/E ratio of 31.91x, a P/B ratio of 5.34x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 90.82% and ROCE of 37.67%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 9.46, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

KRM Ayurveda Share Price is drawing interest today, but the bigger question is whether the supplied fundamentals add context to that attention. On the available numbers, KRM Ayurveda Ltd. is a Rs 642.08 crore company trading at a price-to-earnings ratio of 31.91 and a price-to-book ratio of 5.34. These are valuation multiples, not verdicts by themselves, so they need to be read against profitability and against the company’s industry benchmark. Univest notes that the company’s P/E is close to the industry median rather than standing at an obvious extreme.

Profitability metrics are notable. Return on equity is 90.82%, while return on capital employed is 37.67%. ROE measures returns generated on shareholder equity, and ROCE measures returns on capital employed across the business. On supplied data alone, both numbers are strong enough to stand out in KRM Ayurveda Fundamental Analysis, especially because they can help explain why investors may continue to track the stock even in the absence of a verified event-specific catalyst.

EPS is Rs 9.46, which represents earnings attributable to each share. At the same time, the dividend yield is 0, meaning the stock is not offering a current historical dividend return on the supplied numbers. That shifts the analytical focus more toward earnings power, valuation and operating efficiency than toward income distribution. In KRM Ayurveda Share News, this combination can matter because some market participants will look at whether profitability metrics support a premium to book value or a market-average earnings multiple.

The P/B ratio of 5.34 indicates the market is valuing the stock at well above its accounting net asset base. That can happen when the market assigns importance to profitability or business expectations, though this article does not infer any future outcome. Taken together, KRM Ayurveda Share Price, the 31.91 P/E, 5.34 P/B, 90.82% ROE, 37.67% ROCE and Rs 9.46 EPS create a clearer picture than the price move alone. The next layer is to examine how these figures compare with the Healthcare industry benchmark and listed peers tracked by Univest.

Sector and Industry Context

KRM Ayurveda Ltd. (KRMAYURVED-SM) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

KRM Ayurveda Ltd. (KRMAYURVED-SM) has a P/E ratio of 31.91x, which is below the benchmark median of 32.6x, a difference of -2.12%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

KRM Ayurveda Ltd. (KRMAYURVED-SM) has a ROE of 90.82%, which is above the benchmark median of 13.45%, a difference of +575.24%. KRM Ayurveda Ltd. (KRMAYURVED-SM) has a ROCE of 37.67%, which is above the benchmark median of 17.15%, a difference of +119.65%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

KRM Ayurveda Share Price looks more informative when placed against its industry benchmark. The company sits in the Healthcare sector and Hospital & Healthcare Services industry, and the supplied benchmark covers 42 companies in the same industry. On this basis, KRM Ayurveda’s valuation is not isolated; it can be compared directly with industry medians, averages and observed ranges to see whether the stock is priced above or below broader peer norms.

The company’s P/E ratio is 31.91. That is slightly below the same-industry median P/E of 32.6 and far below the average of 160.94, while still sitting well above the minimum of 7.43 and far below the maximum of 2,997.5. The wide spread between the median and average suggests the benchmark includes outliers, so the median may be the more useful comparison point. On that basis, KRM Ayurveda Share Price appears to be trading on an earnings multiple close to the centre of the peer pack rather than at a sharply stretched level.

The P/B ratio tells a different story. KRM Ayurveda stands at 5.34 versus an industry median of 1.88 and an average of 1.89, with a range from -22.33 to 9.26. That places the company meaningfully above the central industry P/B tendency, implying a richer valuation relative to book value. However, profitability metrics are also stronger than benchmark norms. ROE at 90.82% is well above the benchmark median of 13.45 and the average of 34.25. ROCE at 37.67% is above the median of 17.15 and the average of 20.39.

Scale also matters in sector analysis. KRM Ayurveda’s market capitalisation of Rs 642.08 crore is above the same-industry median market cap of Rs 94.41 crore and also above the average of Rs 427.06 crore, though it remains below the benchmark maximum of Rs 2,537.93 crore. For investors following Stocks in News and Healthcare names in the Indian Stock Market, that combination is important: valuation near the earnings median, book-value multiple above the benchmark centre, and profitability metrics materially above benchmark medians. In Univest’s reading, this makes KRM Ayurveda Share Price worth watching not just because of today’s rise but because of how its ratios compare within the industry set.

Peer Comparison

KRM Ayurveda Ltd. (KRMAYURVED-SM) has a P/E ratio of 31.91x compared with the displayed peer median of 40.47x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 90.82% compares with a peer median of 5.19% across the companies shown in the table. ROCE stood at 37.67% versus the displayed peer median of 22.94%, providing a capital-efficiency comparison. KRM Ayurveda Ltd. (KRMAYURVED-SM) has a market capitalisation of Rs 642.08 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

KRM Ayurveda Share Price also deserves a closer look against named listed peers in Hospital & Healthcare Services. The supplied peer set includes companies such as Dr Agarwals Eye Hospital Ltd., KMC Speciality Hospitals (India) Ltd., Krsnaa Diagnostics Ltd., Shalby Ltd., SURAKSHA DIAGNOSTIC LIMITED, GPT Healthcare Ltd., Unihealth Hospitals Ltd., GUJARAT KIDNEY N SUP SP L and GAUDIUM IVF N WOMEN H L. This peer basket provides a practical framework for stock analysis because it allows direct comparison of market cap, P/E, P/B, ROE and ROCE.

On market capitalisation, KRM Ayurveda at Rs 642.08 crore is smaller than every named peer in the supplied list, where the lowest displayed peer market cap is Rs 953.51 crore for GAUDIUM IVF N WOMEN H L and the highest is Rs 2,537.93 crore for Dr Agarwals Eye Hospital Ltd. That means KRM Ayurveda remains a smaller listed player despite today’s share price rise.

On valuation, the company’s P/E of 31.91 sits below Dr Agarwals Eye Hospital at 33.3, KMC Speciality Hospitals at 41.68, Shalby at 46.35, SURAKSHA at 40.47, Unihealth Hospitals at 47.64, GUJARAT KIDNEY N SUP SP L at 68.38 and GAUDIUM IVF N WOMEN H L at 38.98. It is above GPT Healthcare at 27.5 and Krsnaa Diagnostics at 18.06. So in peer terms, KRM Ayurveda Share Price is neither the cheapest nor the most expensive on earnings.

Profitability is where the company stands out more strongly. ROE of 90.82% is much higher than most peers and is only slightly below GAUDIUM IVF N WOMEN H L at 94.99. It is far above KMC Speciality Hospitals at 22.42, GPT Healthcare at 33.06 and Shalby at 5.19, while Dr Agarwals Eye Hospital shows -2.6. ROCE of 37.67% is also ahead of several peers including Dr Agarwals Eye Hospital at 16.92, KMC Speciality Hospitals at 25.85, SURAKSHA at 22.94, GPT Healthcare at 25.56 and Unihealth Hospitals at 20.33, though it trails Krsnaa Diagnostics at 129.09 and GAUDIUM IVF N WOMEN H L at 82.39.

The peer picture therefore looks mixed but constructive in relative terms: smaller size, mid-pack P/E and strong profitability metrics. For readers searching KRM Ayurveda Stock Analysis or KRM Ayurveda Latest News, this peer comparison helps frame why the stock is being tracked beyond a single-session move. Univest would view the stock as notable for its ratio profile more than for scale within the industry.

Why Investors Are Watching KRM Ayurveda

KRM Ayurveda Share Price is being watched because today’s move combined a threshold-clearing gain with visible trading activity and a profitability profile that stands out within the same-industry dataset. Even without a verified company-specific trigger, the stock has entered the conversation among Top Gainers Today and Stocks Rising Today because both the price action and the comparative financial ratios are measurable and material.

• Verified price action: the stock rose 10.6% from Rs 302 to Rs 334, after opening at Rs 312 and touching Rs 343.95.
• Market-cap context: KRM Ayurveda Ltd. is in the Micro Cap category with market capitalisation of Rs 642.
• Trading activity: 1,57,000 shares changed hands on NSE with turnover of Rs 5.24 crore, keeping the move relevant in Market News and Stock Updates.
• Fundamental backdrop: P/E is 31.91, P/B is 5.34, ROE is 90.82%, ROCE is 37.67% and EPS is Rs 9.46.
• Sector positioning: the company’s P/E is close to the industry median, while ROE and ROCE are above benchmark medians and averages.

What investors may monitor next is whether KRM Ayurveda Share Price continues to hold above the previous close after this move, whether turnover remains elevated, and how the stock’s valuation behaves relative to sector peers. In Univest coverage, that is the practical takeaway: confirmed price rise first, then validation through sustained participation, profitability and relative valuation.

About KRM Ayurveda

KRM Ayurveda Share Price belongs to KRM Ayurveda Ltd., a listed company classified in the Healthcare sector and the Hospital & Healthcare Services industry. The supplied data set does not extend into detailed business segments, product lines or revenue mix, so the factual company context here is based on its market classification and listed market profile rather than on unverified business claims.

Within that framework, KRM Ayurveda operates in a part of the Healthcare space where investors often compare companies on valuation multiples, profitability ratios and market capitalisation because business models can differ across diagnostics, hospitals and specialised healthcare services. In this case, KRM Ayurveda Ltd. is a Micro Cap company with a market capitalisation of Rs 642.08 crore, making it smaller than the named listed peers in the supplied comparison set but larger than the median company size in its same-industry benchmark.

That positioning matters when readers search KRM Ayurveda Company News, KRM Ayurveda NSE or KRM Ayurveda BSE style queries to understand where the company fits. The market currently values it at 31.91 times earnings and 5.34 times book value, while reported profitability stands at 90.82% ROE and 37.67% ROCE. So even with limited descriptive company information, the listed data still shows how the market is presently framing the business: as a smaller Healthcare company with high reported profitability metrics and a stock that has become visible after today’s price rise. Univest will typically place such names in a context led by data, market structure and peer comparison rather than unsupported narratives.

Track KRM Ayurveda Share Price on Univest

Use KRM Ayurveda Ltd. (KRMAYURVED-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

KRM Ayurveda Share Price can be tracked on Univest for live market monitoring beyond today’s move. Users following KRM Ayurveda Share Price Today, KRM Ayurveda Stock News and KRM Ayurveda Share Price Update can use Univest to watch live share price movement, 52-week levels, market capitalisation, valuation ratios, peer data, sector comparison and broader market insights in one place.

For investors who want a structured Market Update, Univest helps connect price action with fundamental analysis by presenting metrics such as P/E ratio, P/B ratio, ROE, ROCE, EPS and industry comparisons in an accessible format. It is also useful for following how names in the Healthcare space appear across Top Gainers Today, NSE News, BSE News and Stock Market Today screens without relying on unverified explanations.

Frequently Asked Questions

Why is KRM Ayurveda Share Price in focus today?

Ans. KRM Ayurveda Share Price is in focus because the stock rose 10.6% to Rs 334 from the previous close of Rs 302, making it a threshold-clearing Micro Cap price rise event with Rs 5.24 crore turnover.

What is KRM Ayurveda Share Price Today?

Ans. KRM Ayurveda Share Price Today is Rs 334 based on the supplied session data. The stock gained Rs 32 during the day, after opening at Rs 312 and reaching an intraday high of Rs 343.95.

How much did KRM Ayurveda stock rise today?

Ans. KRM Ayurveda stock rose by Rs 32, or 10.6%, compared with its previous close of Rs 302. That made it one of the notable stocks gaining today within the Micro Cap category on NSE.

What does today’s price action show for KRM Ayurveda?

Ans. Today’s price action shows a positive session structure for KRM Ayurveda, with the stock opening at Rs 312, staying above that level as the day low, and rising to Rs 343.95 before trading at Rs 334.

What is the market capitalisation of KRM Ayurveda Ltd.?

Ans. KRM Ayurveda Ltd. has a market capitalisation of Rs 642.08 crore in the supplied data. That places the company in the Micro Cap category, which is relevant because today’s price rise cleared its category threshold.

Is KRM Ayurveda expensive compared with its industry on P/E?

Ans. KRM Ayurveda trades at a P/E ratio of 31.91, which is slightly below the same-industry median of 32.6. It is also far below the benchmark average of 160.94, though averages are influenced by high outliers.

How does KRM Ayurveda compare on profitability?

Ans. KRM Ayurveda reports ROE of 90.82% and ROCE of 37.67%. Both are above the same-industry median levels of 13.45 and 17.15 respectively, and also above the benchmark averages of 34.25 and 20.39.

What is the EPS and dividend yield of KRM Ayurveda?

Ans. KRM Ayurveda has an EPS of Rs 9.46 and a dividend yield of 0 in the supplied data. This means the current analytical focus is more on earnings and valuation than on dividend income.

How does KRM Ayurveda compare with listed peers?

Ans. KRM Ayurveda is smaller by market cap than the supplied listed peers, but its P/E of 31.91 sits in the peer range and its ROE of 90.82% stands out against most comparable companies.

What should investors monitor after this KRM Ayurveda Share Price rise?

Ans. Investors may monitor whether KRM Ayurveda Share Price holds above the previous close of Rs 302, whether turnover and volume remain active after today’s 1,57,000-share session, and how valuation compares with Healthcare peers.